The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial
Open accessAbstract
AIMS: Migraine with aura and patent foramen ovale (PFO) are associated. The Percutaneous Closure of PFO in Migraine with Aura (PRIMA) trial is a multicentre, randomized trial to investigate the effect of percutaneous PFO closure in patients refractory to medical treatment. METHODS: Migraine with aura patients and PFO who were unresponsive to preventive medications were randomized to PFO closure or medical treatment. Both groups were given acetylsalicylic acid 75-100 mg/day for 6 months and clopidogrel 75 mg/day for 3 months. The primary endpoint was reduction in monthly migraine days during months 9-12 after randomization compared with a 3-month baseline phase before randomization. The committee reviewing the headache diaries were blinded to treatment assignment. RESULTS: One hundred and seven patients were randomly allocated to treatment with an Amplatzer PFO Occluder (N = 53) or control with medical management (N = 54). The trial was terminated prematurely because of slow enrolment. Eighty-three patients (40 occluder, 43 control) completed 12-month follow-up. Mean migraine days at baseline were 8 (±4.7 SD) in the closure group and 8.3 (±2.4) in controls. The primary endpoint was negative with -2.9 days after PFO closure vs. -1.7 days in control group (P = 0.17). Patent foramen ovale closure caused five adverse events without permanent sequelae. CONCLUSION: In patients with refractory migraine with aura and PFO, PFO closure did not reduce overall monthly migraine days.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696 · cited 1×
“In addition, disability due to migraine, quality of life, and depression were assessed using the Migraine Disability Assessment Questionnaire (MIDAS),(19) Quality of Life Questionnaire SF12v2,(20) and the Beck Depression Inventory (BDI).(21)”
MethodPrevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210
Pathophysiology of the migraine aura: The spreading depression theory
Lauritzen, M. (1994) · Brain · doi:10.1093/brain/117.1.199 · Cited by 1,151
Jenkinson, C., Layte, R., Jenkinson, D., Lawrence, K., Petersen, S., Paice, C., & Stradling, J. (1997) · Journal of Public Health · doi:10.1093/oxfordjournals.pubmed.a024606 · Cited by 971
Cited by
Heart–Brain Axis: Effects of Neurologic Injury on Cardiovascular Function
Tahsili-Fahadan, P., & Geocadin, R. G. (2017) · Circulation Research · doi:10.1161/circresaha.116.308446 · Cited by 291
Mahmoud, A. N., Mentias, A., Elgendy, A. Y., Qazi, A., Barakat, A. F., Saad, M., Mohsen, A., Abuzaid, A., Mansoor, H., Mojadidi, M. K., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020498 · Cited by 287
Metadata
- Authors
- Mattle, H. P., Evers, S., Hildick-Smith, D., Becker, W. J., Baumgartner, H., Chataway, J., Gawel, M., Göbel, H., Heinze, A., Horlick, E., Malik, I., Ray, S., Zermansky, A., Findling, O., Windecker, S., & Meier, B.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-02-22
- Volume
- 37
- Issue
- 26
- Pages
- 2029-2036
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2302536755
- Cited by
- 223
- References
- 5
- FWCI
- 18.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehw027
- The paper
- Mattle, H. P., Evers, S., Hildick-Smith, D., Becker, W. J., Baumgartner, H., Chataway, J., Gawel, M., Göbel, H., Heinze, A., Horlick, E., Malik, I., Ray, S., Zermansky, A., Findling, O., Windecker, S., & Meier, B. (2016). Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehw027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.